Novavax, COVID
Canada not ordering Novavax protein-based COVID vaccine this year due to low demand
TORONTO — The Public Health Agency of Canada says it is not providing Novavax’s COVID-19 vaccine this respiratory virus season, citing lack of demand. It says the manufacturer requires a minimum order of its updated protein-based vaccine, called Nuvaxovid, which far exceeds the uptake by Canadians last year.
Here, doctors explain which COVID-19 vaccine is better when comparing Moderna, Pfizer, and Novovax. Plus, the efficacy of ...
The FDA recently approved the updated mRNA Pfizer and Moderna boosters, as well as the updated Novavax COVID vaccine, to ...
In addition to Pfizer and Moderna's new formulas, Novavax's protein-based shot is an option for COVID vaccination this season ...
Fall means it’s time for just about everybody to get up to date on their flu and COVID-19 vaccines – and a lot of older ...
One of the cornerstones of being prepared for the next pandemic is being in the best position possible to design and deploy a ...
The fall virus season is upon us, and the U.S. Food & Drug Administration just approved one of the newest tools to protect ...
Novavax (NASDAQ:NVAX) shares fell ~3% in the premarket on Thursday after the company issued a clarification on an analyst ...
COVID-19 and flu vaccination campaign is expected to start within days but the Department of Health has yet to announce its ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback